Why the study?
Does intensive early treatment of CKD halt the development of CKD and CVD compared to standard treatment?
Key points are not available for this paper at this time.
Design
Review
We will also assess if early treatment of CKD, intensive compared to standard, has an important effect on the halt of the development of CKD as well as CVD. Insights into the pathogenesis and early recognition of CKD as well as the importance of novel kidney biomarkers will be pointed out. Also, common pathogenetic mechanisms between CKD and CVD will be discussed.
No takes yet. Share an insight, caveat, or question.
Vallianou et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: